Decisions in Action, Delivery in Practice: Adding Flurpiridaz F-18 to Cardiac PET Programs Published on: May 1, 2026
While Cardiac PET continues to expand, adding a new isotope requires complex operational and financial decisions beyond image quality. In this session, a cardiovascular imaging leader will share their end-to-end approach to implementing Flurpiridaz F-18, from building business cards to adjusting workflows, staffing, scheduling and prior authorization. Attendees will receive a practical, high-level overview of best practices for evaluating and scaling a cardiac PET program.
Speakers:
By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.